280 related articles for article (PubMed ID: 26080339)
1. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model.
Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M
JAMA; 2015 Jun; 313(23):2349-58. PubMed ID: 26080339
[TBL] [Abstract][Full Text] [Related]
2. Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer.
Meester RGS; Doubeni CA; Zauber AG; van Ballegooijen M; Corley DA; Lansdorp-Vogelaar I
Int J Cancer; 2017 Dec; 141(11):2359-2367. PubMed ID: 28815573
[TBL] [Abstract][Full Text] [Related]
3. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.
Knudsen AB; Zauber AG; Rutter CM; Naber SK; Doria-Rose VP; Pabiniak C; Johanson C; Fischer SE; Lansdorp-Vogelaar I; Kuntz KM
JAMA; 2016 Jun; 315(23):2595-609. PubMed ID: 27305518
[TBL] [Abstract][Full Text] [Related]
5. Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer.
Schottinger JE; Jensen CD; Ghai NR; Chubak J; Lee JK; Kamineni A; Halm EA; Sugg-Skinner C; Udaltsova N; Zhao WK; Ziebell RA; Contreras R; Kim EJ; Fireman BH; Quesenberry CP; Corley DA
JAMA; 2022 Jun; 327(21):2114-2122. PubMed ID: 35670788
[TBL] [Abstract][Full Text] [Related]
6. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
7. Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death.
Kaminski MF; Wieszczy P; Rupinski M; Wojciechowska U; Didkowska J; Kraszewska E; Kobiela J; Franczyk R; Rupinska M; Kocot B; Chaber-Ciopinska A; Pachlewski J; Polkowski M; Regula J
Gastroenterology; 2017 Jul; 153(1):98-105. PubMed ID: 28428142
[TBL] [Abstract][Full Text] [Related]
8. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
[No Abstract] [Full Text] [Related]
9. Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs.
Austin GL; Fennimore B; Ahnen DJ
Am J Gastroenterol; 2013 Mar; 108(3):296-301. PubMed ID: 23208273
[TBL] [Abstract][Full Text] [Related]
10. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
Knudsen AB; Hur C; Gazelle GS; Schrag D; McFarland EG; Kuntz KM
Ann Intern Med; 2012 Nov; 157(9):611-20. PubMed ID: 23128861
[TBL] [Abstract][Full Text] [Related]
11. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
12. The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.
Steer KJ; Sun Z; Sadowski DC; Yong JHE; Coldman A; Nemecek N; Yang H
J Med Screen; 2024 Jun; 31(2):78-84. PubMed ID: 37728194
[TBL] [Abstract][Full Text] [Related]
13. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
[TBL] [Abstract][Full Text] [Related]
14. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
Knudsen AB; Rutter CM; Peterse EFP; Lietz AP; Seguin CL; Meester RGS; Perdue LA; Lin JS; Siegel RL; Doria-Rose VP; Feuer EJ; Zauber AG; Kuntz KM; Lansdorp-Vogelaar I
JAMA; 2021 May; 325(19):1998-2011. PubMed ID: 34003219
[TBL] [Abstract][Full Text] [Related]
16. Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring.
Kaltenbach T; Gawron A; Meyer CS; Gupta S; Shergill A; Dominitz JA; Soetikno RM; Nguyen-Vu T; A Whooley M; Kahi CJ
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1883-1889.e1. PubMed ID: 33618027
[TBL] [Abstract][Full Text] [Related]
17. An Evaluation of Critical Factors for the Cost-Effectiveness of Real-Time Computer-Aided Detection: Sensitivity and Threshold Analyses Using a Microsimulation Model.
Thiruvengadam NR; Coté GA; Gupta S; Rodrigues M; Schneider Y; Arain MA; Solaimani P; Serrao S; Kochman ML; Saumoy M
Gastroenterology; 2023 May; 164(6):906-920. PubMed ID: 36736437
[TBL] [Abstract][Full Text] [Related]
18. Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies.
Penz D; Ferlitsch A; Waldmann E; Irina G; Daniel P; Asaturi A; Hinterberger A; Majcher B; Szymanska A; Trauner M; Ferlitsch M
Gastrointest Endosc; 2020 Jan; 91(1):135-141. PubMed ID: 31499041
[TBL] [Abstract][Full Text] [Related]
19. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.
Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I
Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616
[TBL] [Abstract][Full Text] [Related]
20. Nonneoplastic polypectomy during screening colonoscopy: the impact on polyp detection rate, adenoma detection rate, and overall cost.
Atia MA; Patel NC; Ratuapli SK; Boroff ES; Crowell MD; Gurudu SR; Faigel DO; Leighton JA; Ramirez FC
Gastrointest Endosc; 2015 Aug; 82(2):370-375.e1. PubMed ID: 25843614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
